P

Pierrel SpA
MIL:PRL

Watchlist Manager
Pierrel SpA
MIL:PRL
Watchlist
Price: 1.745 EUR Market Closed
Market Cap: 95.9m EUR
Have any thoughts about
Pierrel SpA?
Write Note

Pierrel SpA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pierrel SpA
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
Pierrel SpA
MIL:PRL
Operating Income
€3.5m
CAGR 3-Years
-5%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Operating Income
-€15m
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Operating Income
€637.4m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
11%
Friulchem SpA
MIL:FCM
Operating Income
€592.9k
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Operating Income
€8.5m
CAGR 3-Years
10%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Pierrel SpA
Glance View

Market Cap
95.9m EUR
Industry
Pharmaceuticals

Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. The company is headquartered in Capua, Caserta. The company went IPO on 2006-05-23. The firm specializes in the pharmaceutical research, development and the manufacture of medicines. The company operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. The company manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.

PRL Intrinsic Value
1.849 EUR
Undervaluation 6%
Intrinsic Value
Price
P

See Also

What is Pierrel SpA's Operating Income?
Operating Income
3.5m EUR

Based on the financial report for Jun 30, 2023, Pierrel SpA's Operating Income amounts to 3.5m EUR.

What is Pierrel SpA's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Pierrel SpA have been -5% over the past three years , 11% over the past five years .

Back to Top